ArticleNagoya journal of medical science2025
Atypical hemolytic uremic syndrome treated with anti-C5 antibody agent eculizumab, without genetic complement abnormalities.
Yuka Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.